Mr. Speaker, our government is committed to improving access to necessary prescription medications including orphan drugs as we understand the difficulties experienced by people dealing with rare medical conditions. To that end, we have launched a regulatory review of drugs and devices initiative, a major effort to improve the availability of prescription medications including drugs for rare diseases.
Last year, our government authorized 36 new drugs and we look forward to the health committee's report on rare diseases.